Literature DB >> 19899413

Dosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformal radiotherapy in patients with gynecologic malignancies.

S Iğdem1, T Ercan, G Alço, F Zengin, R Ozgüleş, G Geceer, S Okkan, A Ober, S Turkan.   

Abstract

PURPOSE: Before initiating an intensity modulated radiotherapy (IMRT) program for gynecologic malignancies we prospectively evaluated the potential benefits of IMRT by dose volume histogram comparison of IMRT and 3D conformal radiotherapy plans.
METHODS: Plans of ten consecutive patients with cervical and endometrial cancer were evaluated. For each patient a 4-field box technique was compared to an IMRT plan. Both plans were normalized to deliver 50.4 Gy to the PTV in six patients and 45 Gy in the remaining four. Isodose distributions and dose volume histograms were compared in seven dose levels.
RESULTS: IMRT reduced the volume of small bowel receiving more than 45 Gy in all patients. The average absolute volume of small bowel receiving 45 Gy was significantly reduced from 318 cc to 33 cc. No significant increase in the volume of small bowel receiving less than 20 Gy was observed. Rectum, bladder and bone marrow volumes receiving high doses were also significantly reduced with IMRT.
CONCLUSIONS: IMRT significantly reduces the volume of normal tissues irradiated to high doses without compromising the target coverage. This may potentially lead to a reduction in treatment related toxicities.

Entities:  

Mesh:

Year:  2009        PMID: 19899413

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study.

Authors:  Xue-lian Du; Xiu-gui Sheng; Tao Jiang; Hao Yu; Yu-feng Yan; Rong Gao; Chun-hua Lu; Qing-shui Li
Journal:  Croat Med J       Date:  2010-06       Impact factor: 1.351

2.  Feasibility study of pelvic helical IMRT for elderly patients with endometrial cancer.

Authors:  Jean-Emmanuel Bibault; Philippe Nickers; Emmanuelle Tresch; Abel Cordoba; Eric Leblanc; Pauline Comte; Thomas Lacornerie; Eric Lartigau
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

3.  Long-Term Follow-Up Results of Adjuvant Intensity-Modulated Radiotherapy with Concurrent Paclitaxel and Cisplatin in High-Risk Endometrial Cancer Patients.

Authors:  Pei Shu; Xin Wang; Ganlu Ouyang; Jitao Zhou; Yaqin Zhao; Fang Wang; Zhiping Li; Yali Shen
Journal:  J Oncol       Date:  2022-10-11       Impact factor: 4.501

Review 4.  Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis.

Authors:  Baojuan Yang; Lin Zhu; Haiyan Cheng; Qi Li; Yunyan Zhang; Yashuang Zhao
Journal:  Radiat Oncol       Date:  2012-11-23       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.